Skip Navigation
National Cancer Institute

Funding Opportunities

There are many funding opportunities that support the conduct of rigorous, cutting-edge dissemination and implementation research at the National Cancer Institute and across the National Institutes of Health. The most prominent funding opportunity is the Trans-NIH program announcement with special receipt, referral and/or review (PAR), Dissemination and Implementation Research in Health. The National Cancer Institute, along with many other participating institutes and centers across the National Institutes of Health, has issued this PAR for R03, R21 and/or R01 funding mechanisms. Below, we provide additional information about this implementation science (IS) funding opportunity as well as resources for prospective IS applicants.

Apply for Grants

  • Trans-NIH PAR, Dissemination and Implementation Research in Health
    • R01, Dissemination and Implementation Research in Health
    • R21, Dissemination and Implementation Research in Health
      • Note: The R21 exploratory/developmental grant mechanism supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information. Preliminary data are not required for R21 applications; however, they may be included if available.
    • R03, Dissemination and Implementation Research in Health
      • Note: The R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Because the research project usually is limited, an R03 grant application may not contain extensive detail or discussion. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies.

Resources for Prospective Grantees

  • Webinar
    • In May 2016, the Trans-NIH PARs in Dissemination and Implementation Research in Health were re-issued (R01, R21, and R03). Drs. David Chambers, Deputy Director, Implementation Science and XX [TBD others?] hosted a webinar to provide updated information on the re-issued PAR. The webinar is free and readily available with [XX software/platform?] here [add link].

  • Study Section
    • As stated by the NIH Center for Scientific Review (CSR), the Dissemination and Implementation Research in Health (DIRH) Study Section reviews applications intending to bridge the gap between public health, clinical research, and everyday practice by building a scientific knowledge base about mechanisms whereby health information, interventions, and scientifically based clinical practices are adopted in public health and health care service use in a variety of settings. The focus of the studies reviewed is on the transmission and implementation of knowledge from scientific discovery to transform health care delivery, improve health outcomes, and manage acute and chronic illness. Click here to see the DIRH Membership Roster and the DIRH Meeting Roster.

  • Portfolio Analysis
    • In 2015, IS team members published a portfolio analysis of dissemination and implementation grants funded by the NCI in cancer prevention and control from 2000 to 2012. A free copy of the peer-reviewed article (Neta et al., 2015) is available here. The portfolio analysis identified 67 NCI grant awards with an implementation science focus. The R01 mechanism was the most common funding mechanism. Cancer prevention-focused grants were most common (49.3%) and cancer treatment grants were least common (4.5%). Most grants also included both quantitative and qualitative methods (69%).

  • Current and Completed Grants
    • To see a list of current dissemination and implementation grants funded through the Dissemination and Implementation Research in Health FOA in cancer prevention and control by DCCPS: R01, R21, or R03.

  • FAQ (Forthcoming)

General Grant Resources